| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.63B | 70.25B | 44.75B | 33.58B | 29.34B | 20.55B |
| Gross Profit | 24.44B | 17.65B | 27.34B | 23.61B | 22.29B | 18.41B |
| EBITDA | 33.62B | 25.47B | 26.88B | 17.15B | 18.53B | 21.54B |
| Net Income | 7.24B | 2.69B | 8.86B | 2.68B | 1.58B | 11.51B |
Balance Sheet | ||||||
| Total Assets | 599.06B | 529.81B | 465.16B | 303.38B | 296.22B | 220.55B |
| Cash, Cash Equivalents and Short-Term Investments | 86.48B | 87.47B | 66.49B | 49.63B | 44.28B | 40.36B |
| Total Debt | 347.13B | 332.92B | 306.87B | 206.08B | 207.10B | 160.41B |
| Total Liabilities | 426.43B | 396.63B | 359.70B | 238.65B | 243.78B | 195.68B |
| Stockholders Equity | 112.32B | 88.87B | 67.77B | 42.95B | 31.89B | 15.25B |
Cash Flow | ||||||
| Free Cash Flow | 18.33B | 23.00B | 2.82B | -804.00M | -3.35B | 6.85B |
| Operating Cash Flow | 26.43B | 31.50B | 18.73B | 10.13B | 12.15B | 12.47B |
| Investing Cash Flow | -18.14B | -16.50B | -24.35B | -9.33B | -18.52B | -13.48B |
| Financing Cash Flow | -14.72B | -8.29B | 1.38B | 3.03B | 3.37B | 9.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥751.78B | 6.68 | 7.17% | 3.22% | -1.56% | 9.17% | |
74 Outperform | ¥74.27B | 5.57 | ― | 1.79% | -15.80% | ― | |
71 Outperform | ¥219.59B | 13.52 | 13.70% | 2.36% | -1.60% | -10.41% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥357.35B | 16.42 | 12.27% | 3.23% | -1.02% | 79.80% | |
63 Neutral | ¥57.03B | 3.56 | 4.73% | 2.31% | -1.96% | 33.15% | |
57 Neutral | ¥88.92B | 48.38 | 7.71% | ― | 28.85% | -9.70% |